Wakabayashi N, Yagishita Y, Joshi T, Kensler T
Int J Mol Sci. 2024; 25(9).
PMID: 38731931
PMC: 11083431.
DOI: 10.3390/ijms25094712.
Li Y, Liu X, Sun X, Li H, Wang S, Tian W
Protein Cell. 2024; 15(11):818-839.
PMID: 38635907
PMC: 11528516.
DOI: 10.1093/procel/pwae016.
Architha T, Juanitaa G, Vijayalalitha R, Jayasuriya R, Athira G, Balamurugan R
Cells. 2024; 13(5.
PMID: 38474419
PMC: 10931324.
DOI: 10.3390/cells13050456.
Verkade E, Shen W, Hovingh M, Mulder N, de Bruyn K, Koehorst M
Clin Sci (Lond). 2023; 137(21):1637-1650.
PMID: 37910096
PMC: 10643054.
DOI: 10.1042/CS20230812.
Jia W, Li Y, Cheung K, Zheng X
Sci China Life Sci. 2023; 67(5):865-878.
PMID: 37515688
DOI: 10.1007/s11427-023-2353-0.
Circadian PER1 controls daily fat absorption with the regulation of PER1-PKA on phosphorylation of bile acid synthetase.
Ge W, Sun Q, Yang Y, Ding Z, Liu J, Zhang J
J Lipid Res. 2023; 64(6):100390.
PMID: 37209828
PMC: 10276160.
DOI: 10.1016/j.jlr.2023.100390.
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.
Yang Y, Ye X, Zhang H, Lin Z, Fang M, Wang J
Front Genet. 2023; 13:1068837.
PMID: 36685838
PMC: 9845592.
DOI: 10.3389/fgene.2022.1068837.
Hepatic nonvesicular cholesterol transport is critical for systemic lipid homeostasis.
Xiao X, Kennelly J, Ferrari A, Clifford B, Whang E, Gao Y
Nat Metab. 2023; 5(1):165-181.
PMID: 36646756
PMC: 9995220.
DOI: 10.1038/s42255-022-00722-6.
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation.
Alonso-Pena M, Espinosa-Escudero R, Hermanns H, Briz O, Herranz J, Garcia-Ruiz C
Cells. 2022; 11(24).
PMID: 36552746
PMC: 9777420.
DOI: 10.3390/cells11243983.
Mechanisms for Bile Acids CDCA- and DCA-Stimulated Hepatic Spexin Expression.
Lai Q, Ma Y, Bai J, Zhuang M, Pei S, He N
Cells. 2022; 11(14).
PMID: 35883602
PMC: 9316865.
DOI: 10.3390/cells11142159.
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis.
Di Vincenzo F, Puca P, Lopetuso L, Petito V, Masi L, Bartocci B
Nutrients. 2022; 14(13).
PMID: 35807844
PMC: 9268369.
DOI: 10.3390/nu14132664.
Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.
Kim D, Choi H, Park J, Kim C, Bae E, Ma S
Redox Biol. 2022; 54:102382.
PMID: 35767918
PMC: 9241134.
DOI: 10.1016/j.redox.2022.102382.
A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction-Related Diseases.
Weng Z, Chen Y, Lv J, Wang M, Chen Z, Zhou W
Oxid Med Cell Longev. 2022; 2022:4289383.
PMID: 35308170
PMC: 8933076.
DOI: 10.1155/2022/4289383.
Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism.
Zhou W, Anakk S
Mol Cell Endocrinol. 2022; 549:111616.
PMID: 35304191
PMC: 9245558.
DOI: 10.1016/j.mce.2022.111616.
Proteome-scale profiling reveals MAFF and MAFG as two novel key transcription factors involved in palmitic acid-induced umbilical vein endothelial cell apoptosis.
Wang M, Liu F, Fang B, Huo Q, Yang Y
BMC Cardiovasc Disord. 2021; 21(1):448.
PMID: 34535081
PMC: 8447594.
DOI: 10.1186/s12872-021-02246-5.
Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis.
Chiang J, Ferrell J
Liver Res. 2021; 4(2):47-63.
PMID: 34290896
PMC: 8291349.
DOI: 10.1016/j.livres.2020.05.001.
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption.
Clifford B, Sedgeman L, Williams K, Morand P, Cheng A, Jarrett K
Cell Metab. 2021; 33(8):1671-1684.e4.
PMID: 34270928
PMC: 8353952.
DOI: 10.1016/j.cmet.2021.06.012.
Hepatic transcriptional responses to fasting and feeding.
Bideyan L, Nagari R, Tontonoz P
Genes Dev. 2021; 35(9-10):635-657.
PMID: 33888557
PMC: 8091980.
DOI: 10.1101/gad.348340.121.
Hepatic miR-378 modulates serum cholesterol levels by regulating hepatic bile acid synthesis.
Sun C, Liu W, Lu Z, Li Y, Liu S, Tang Z
Theranostics. 2021; 11(9):4363-4380.
PMID: 33754066
PMC: 7977473.
DOI: 10.7150/thno.53624.
BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
Jung H, Chen J, Hu X, Sun H, Wu S, Chiang C
JCI Insight. 2020; 6(1).
PMID: 33290278
PMC: 7821603.
DOI: 10.1172/jci.insight.141640.